鎮痛剤の世界市場 2020年

• 英文タイトル：Global Drugs for Pain Management Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：GIR201114237 • 出版社/出版日：GlobalInfoResearch / 2020年10月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、126ページ • 納品方法：Eメール • 産業分類：医薬品・医療

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本書では、鎮痛剤の世界市場を調査対象にし、鎮痛剤の市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（ジェネリックオピオイド、ブランドオピオイド、NSAID、その他）、用途別分析（病院、ドラッグストア、その他）、市場予測（2021年～2025年）情報などを整理しました。 ・市場概要 ・企業情報：GSK、Endo、Sanofi、Pfizer、Eli Lilly、Grunenthal、Yunnan Baiyao、AstraZeneca、Bayer、Merck、Allergan、Teikoku Seiyaku、Assertio Therapeutics、Teva、J&J ・企業別売上、市場シェア ・鎮痛剤の地域別市場分析 ・鎮痛剤の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・鎮痛剤のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・鎮痛剤のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・鎮痛剤の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・鎮痛剤の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・鎮痛剤の種類別市場規模2015-2020：ジェネリックオピオイド、ブランドオピオイド、NSAID、その他 ・鎮痛剤の用途別市場規模2015-2020：病院、ドラッグストア、その他 ・鎮痛剤の世界市場予測2021-2025：地域別、種類別、用途別 ・調査の結果・結論

Market Overview
The global Drugs for Pain Management market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Drugs for Pain Management market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Drugs for Pain Management market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Drugs for Pain Management market has been segmented into:
Generic Opioid
Branded Opioids
NSAIDs
Others

By Application, Drugs for Pain Management has been segmented into:
Hospitals
Drugstores
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Drugs for Pain Management market presented in the report. This section sheds light on the sales growth of different regional and country-level Drugs for Pain Management markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Drugs for Pain Management market.

The report offers in-depth assessment of the growth and other aspects of the Drugs for Pain Management market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Drugs for Pain Management Market Share Analysis
Drugs for Pain Management competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Drugs for Pain Management sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Drugs for Pain Management sales, revenue and market share for each player covered in this report.

The major players covered in Drugs for Pain Management are:
GSK
Endo
Sanofi
Pfizer
Eli Lilly
Grunenthal
Yunnan Baiyao
AstraZeneca
Bayer
Merck
Allergan
Teikoku Seiyaku
Assertio Therapeutics
Teva
J&J

レポート目次

---

Table of Contents

1 Drugs for Pain Management Market Overview
1.1 Product Overview and Scope of Drugs for Pain Management
1.2 Classification of Drugs for Pain Management by Type
1.2.1 Global Drugs for Pain Management Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Drugs for Pain Management Revenue Market Share by Type in 2019
1.2.3 Generic Opioid
1.2.4 Branded Opioids
1.2.5 NSAIDs
1.2.6 Others
1.3 Global Drugs for Pain Management Market by Application
1.3.1 Overview: Global Drugs for Pain Management Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Drugstores
1.3.4 Others
1.4 Global Drugs for Pain Management Market by Regions
1.4.1 Global Drugs for Pain Management Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Drugs for Pain Management (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Drugs for Pain Management Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Drugs for Pain Management Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Drugs for Pain Management Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Drugs for Pain Management Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Drugs for Pain Management Status and Prospect (2015-2025)
2 Company Profiles
2.1 GSK
2.1.1 GSK Details
2.1.2 GSK Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 GSK SWOT Analysis
2.1.4 GSK Product and Services
2.1.5 GSK Drugs for Pain Management Revenue, Gross Margin and Market Share (2018-2019)
2.2 Endo
2.2.1 Endo Details
2.2.2 Endo Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Endo SWOT Analysis
2.2.4 Endo Product and Services
2.2.5 Endo Drugs for Pain Management Revenue, Gross Margin and Market Share (2018-2019)
2.3 Sanofi
2.3.1 Sanofi Details
2.3.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Sanofi SWOT Analysis
2.3.4 Sanofi Product and Services
2.3.5 Sanofi Drugs for Pain Management Revenue, Gross Margin and Market Share (2018-2019)
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Pfizer SWOT Analysis
2.4.4 Pfizer Product and Services
2.4.5 Pfizer Drugs for Pain Management Revenue, Gross Margin and Market Share (2018-2019)
2.5 Eli Lilly
2.5.1 Eli Lilly Details
2.5.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Eli Lilly SWOT Analysis
2.5.4 Eli Lilly Product and Services
2.5.5 Eli Lilly Drugs for Pain Management Revenue, Gross Margin and Market Share (2018-2019)
2.6 Grunenthal
2.6.1 Grunenthal Details
2.6.2 Grunenthal Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Grunenthal SWOT Analysis
2.6.4 Grunenthal Product and Services
2.6.5 Grunenthal Drugs for Pain Management Revenue, Gross Margin and Market Share (2018-2019)
2.7 Yunnan Baiyao
2.7.1 Yunnan Baiyao Details
2.7.2 Yunnan Baiyao Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Yunnan Baiyao SWOT Analysis
2.7.4 Yunnan Baiyao Product and Services
2.7.5 Yunnan Baiyao Drugs for Pain Management Revenue, Gross Margin and Market Share (2018-2019)
2.8 AstraZeneca
2.8.1 AstraZeneca Details
2.8.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 AstraZeneca SWOT Analysis
2.8.4 AstraZeneca Product and Services
2.8.5 AstraZeneca Drugs for Pain Management Revenue, Gross Margin and Market Share (2018-2019)
2.9 Bayer
2.9.1 Bayer Details
2.9.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Bayer SWOT Analysis
2.9.4 Bayer Product and Services
2.9.5 Bayer Drugs for Pain Management Revenue, Gross Margin and Market Share (2018-2019)
2.10 Merck
2.10.1 Merck Details
2.10.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Merck SWOT Analysis
2.10.4 Merck Product and Services
2.10.5 Merck Drugs for Pain Management Revenue, Gross Margin and Market Share (2018-2019)
2.11 Allergan
2.11.1 Allergan Details
2.11.2 Allergan Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Allergan SWOT Analysis
2.11.4 Allergan Product and Services
2.11.5 Allergan Drugs for Pain Management Revenue, Gross Margin and Market Share (2018-2019)
2.12 Teikoku Seiyaku
2.12.1 Teikoku Seiyaku Details
2.12.2 Teikoku Seiyaku Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Teikoku Seiyaku SWOT Analysis
2.12.4 Teikoku Seiyaku Product and Services
2.12.5 Teikoku Seiyaku Drugs for Pain Management Revenue, Gross Margin and Market Share (2018-2019)
2.13 Assertio Therapeutics
2.13.1 Assertio Therapeutics Details
2.13.2 Assertio Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Assertio Therapeutics SWOT Analysis
2.13.4 Assertio Therapeutics Product and Services
2.13.5 Assertio Therapeutics Drugs for Pain Management Revenue, Gross Margin and Market Share (2018-2019)
2.14 Teva
2.14.1 Teva Details
2.14.2 Teva Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Teva SWOT Analysis
2.14.4 Teva Product and Services
2.14.5 Teva Drugs for Pain Management Revenue, Gross Margin and Market Share (2018-2019)
2.15 J&J
2.15.1 J&J Details
2.15.2 J&J Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 J&J SWOT Analysis
2.15.4 J&J Product and Services
2.15.5 J&J Drugs for Pain Management Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Drugs for Pain Management Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Drugs for Pain Management Players Market Share
3.2.2 Top 10 Drugs for Pain Management Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Drugs for Pain Management Revenue and Market Share by Regions
4.2 North America Drugs for Pain Management Revenue and Growth Rate (2015-2020)
4.3 Europe Drugs for Pain Management Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Drugs for Pain Management Revenue and Growth Rate (2015-2020)
4.5 South America Drugs for Pain Management Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Drugs for Pain Management Revenue and Growth Rate (2015-2020)
5 North America Drugs for Pain Management Revenue by Countries
5.1 North America Drugs for Pain Management Revenue by Countries (2015-2020)
5.2 USA Drugs for Pain Management Revenue and Growth Rate (2015-2020)
5.3 Canada Drugs for Pain Management Revenue and Growth Rate (2015-2020)
5.4 Mexico Drugs for Pain Management Revenue and Growth Rate (2015-2020)
6 Europe Drugs for Pain Management Revenue by Countries
6.1 Europe Drugs for Pain Management Revenue by Countries (2015-2020)
6.2 Germany Drugs for Pain Management Revenue and Growth Rate (2015-2020)
6.3 UK Drugs for Pain Management Revenue and Growth Rate (2015-2020)
6.4 France Drugs for Pain Management Revenue and Growth Rate (2015-2020)
6.5 Russia Drugs for Pain Management Revenue and Growth Rate (2015-2020)
6.6 Italy Drugs for Pain Management Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Drugs for Pain Management Revenue by Countries
7.1 Asia-Pacific Drugs for Pain Management Revenue by Countries (2015-2020)
7.2 China Drugs for Pain Management Revenue and Growth Rate (2015-2020)
7.3 Japan Drugs for Pain Management Revenue and Growth Rate (2015-2020)
7.4 Korea Drugs for Pain Management Revenue and Growth Rate (2015-2020)
7.5 India Drugs for Pain Management Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Drugs for Pain Management Revenue and Growth Rate (2015-2020)
8 South America Drugs for Pain Management Revenue by Countries
8.1 South America Drugs for Pain Management Revenue by Countries (2015-2020)
8.2 Brazil Drugs for Pain Management Revenue and Growth Rate (2015-2020)
8.3 Argentina Drugs for Pain Management Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Drugs for Pain Management by Countries
9.1 Middle East & Africa Drugs for Pain Management Revenue by Countries (2015-2020)
9.2 Saudi Arabia Drugs for Pain Management Revenue and Growth Rate (2015-2020)
9.3 UAE Drugs for Pain Management Revenue and Growth Rate (2015-2020)
9.4 Egypt Drugs for Pain Management Revenue and Growth Rate (2015-2020)
9.5 South Africa Drugs for Pain Management Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Drugs for Pain Management Revenue and Market Share by Type (2015-2020)
10.2 Global Drugs for Pain Management Market Forecast by Type (2019-2024)
10.3 Generic Opioid Revenue Growth Rate (2015-2025)
10.4 Branded Opioids Revenue Growth Rate (2015-2025)
10.5 NSAIDs Revenue Growth Rate (2015-2025)
10.6 Others Revenue Growth Rate (2015-2025)
11 Global Drugs for Pain Management Market Segment by Application
11.1 Global Drugs for Pain Management Revenue Market Share by Application (2015-2020)
11.2 Drugs for Pain Management Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Drugstores Revenue Growth (2015-2020)
11.5 Others Revenue Growth (2015-2020)
12 Global Drugs for Pain Management Market Size Forecast (2021-2025)
12.1 Global Drugs for Pain Management Market Size Forecast (2021-2025)
12.2 Global Drugs for Pain Management Market Forecast by Regions (2021-2025)
12.3 North America Drugs for Pain Management Revenue Market Forecast (2021-2025)
12.4 Europe Drugs for Pain Management Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Drugs for Pain Management Revenue Market Forecast (2021-2025)
12.6 South America Drugs for Pain Management Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Drugs for Pain Management Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global Drugs for Pain Management Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Drugs for Pain Management by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Drugs for Pain Management Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Drugs for Pain Management Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. GSK Corporate Information, Location and Competitors
Table 6. GSK Drugs for Pain Management Major Business
Table 7. GSK Drugs for Pain Management Total Revenue (USD Million) (2017-2018)
Table 8. GSK SWOT Analysis
Table 9. GSK Drugs for Pain Management Product and Solutions
Table 10. GSK Drugs for Pain Management Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Endo Corporate Information, Location and Competitors
Table 12. Endo Drugs for Pain Management Major Business
Table 13. Endo Drugs for Pain Management Total Revenue (USD Million) (2018-2019)
Table 14. Endo SWOT Analysis
Table 15. Endo Drugs for Pain Management Product and Solutions
Table 16. Endo Drugs for Pain Management Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Sanofi Corporate Information, Location and Competitors
Table 18. Sanofi Drugs for Pain Management Major Business
Table 19. Sanofi Drugs for Pain Management Total Revenue (USD Million) (2017-2018)
Table 20. Sanofi SWOT Analysis
Table 21. Sanofi Drugs for Pain Management Product and Solutions
Table 22. Sanofi Drugs for Pain Management Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Pfizer Corporate Information, Location and Competitors
Table 24. Pfizer Drugs for Pain Management Major Business
Table 25. Pfizer Drugs for Pain Management Total Revenue (USD Million) (2017-2018)
Table 26. Pfizer SWOT Analysis
Table 27. Pfizer Drugs for Pain Management Product and Solutions
Table 28. Pfizer Drugs for Pain Management Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Eli Lilly Corporate Information, Location and Competitors
Table 30. Eli Lilly Drugs for Pain Management Major Business
Table 31. Eli Lilly Drugs for Pain Management Total Revenue (USD Million) (2017-2018)
Table 32. Eli Lilly SWOT Analysis
Table 33. Eli Lilly Drugs for Pain Management Product and Solutions
Table 34. Eli Lilly Drugs for Pain Management Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Grunenthal Corporate Information, Location and Competitors
Table 36. Grunenthal Drugs for Pain Management Major Business
Table 37. Grunenthal Drugs for Pain Management Total Revenue (USD Million) (2017-2018)
Table 38. Grunenthal SWOT Analysis
Table 39. Grunenthal Drugs for Pain Management Product and Solutions
Table 40. Grunenthal Drugs for Pain Management Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Yunnan Baiyao Corporate Information, Location and Competitors
Table 42. Yunnan Baiyao Drugs for Pain Management Major Business
Table 43. Yunnan Baiyao Drugs for Pain Management Total Revenue (USD Million) (2017-2018)
Table 44. Yunnan Baiyao SWOT Analysis
Table 45. Yunnan Baiyao Drugs for Pain Management Product and Solutions
Table 46. Yunnan Baiyao Drugs for Pain Management Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. AstraZeneca Corporate Information, Location and Competitors
Table 48. AstraZeneca Drugs for Pain Management Major Business
Table 49. AstraZeneca Drugs for Pain Management Total Revenue (USD Million) (2017-2018)
Table 50. AstraZeneca SWOT Analysis
Table 51. AstraZeneca Drugs for Pain Management Product and Solutions
Table 52. AstraZeneca Drugs for Pain Management Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Bayer Corporate Information, Location and Competitors
Table 54. Bayer Drugs for Pain Management Major Business
Table 55. Bayer Drugs for Pain Management Total Revenue (USD Million) (2017-2018)
Table 56. Bayer SWOT Analysis
Table 57. Bayer Drugs for Pain Management Product and Solutions
Table 58. Bayer Drugs for Pain Management Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Merck Corporate Information, Location and Competitors
Table 60. Merck Drugs for Pain Management Major Business
Table 61. Merck Drugs for Pain Management Total Revenue (USD Million) (2017-2018)
Table 62. Merck SWOT Analysis
Table 63. Merck Drugs for Pain Management Product and Solutions
Table 64. Merck Drugs for Pain Management Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Allergan Corporate Information, Location and Competitors
Table 66. Allergan Drugs for Pain Management Major Business
Table 67. Allergan Drugs for Pain Management Total Revenue (USD Million) (2017-2018)
Table 68. Allergan SWOT Analysis
Table 69. Allergan Drugs for Pain Management Product and Solutions
Table 70. Allergan Drugs for Pain Management Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Teikoku Seiyaku Corporate Information, Location and Competitors
Table 72. Teikoku Seiyaku Drugs for Pain Management Major Business
Table 73. Teikoku Seiyaku Drugs for Pain Management Total Revenue (USD Million) (2017-2018)
Table 74. Teikoku Seiyaku SWOT Analysis
Table 75. Teikoku Seiyaku Drugs for Pain Management Product and Solutions
Table 76. Teikoku Seiyaku Drugs for Pain Management Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Assertio Therapeutics Corporate Information, Location and Competitors
Table 78. Assertio Therapeutics Drugs for Pain Management Major Business
Table 79. Assertio Therapeutics Drugs for Pain Management Total Revenue (USD Million) (2017-2018)
Table 80. Assertio Therapeutics SWOT Analysis
Table 81. Assertio Therapeutics Drugs for Pain Management Product and Solutions
Table 82. Assertio Therapeutics Drugs for Pain Management Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. Teva Corporate Information, Location and Competitors
Table 84. Teva Drugs for Pain Management Major Business
Table 85. Teva Drugs for Pain Management Total Revenue (USD Million) (2017-2018)
Table 86. Teva SWOT Analysis
Table 87. Teva Drugs for Pain Management Product and Solutions
Table 88. Teva Drugs for Pain Management Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 89. J&J Corporate Information, Location and Competitors
Table 90. J&J Drugs for Pain Management Major Business
Table 91. J&J Drugs for Pain Management Total Revenue (USD Million) (2017-2018)
Table 92. J&J SWOT Analysis
Table 93. J&J Drugs for Pain Management Product and Solutions
Table 94. J&J Drugs for Pain Management Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 95. Global Drugs for Pain Management Revenue (Million USD) by Players (2015-2020)
Table 96. Global Drugs for Pain Management Revenue Share by Players (2015-2020)
Table 97. Global Drugs for Pain Management Revenue (Million USD) by Regions (2015-2020)
Table 98. Global Drugs for Pain Management Revenue Market Share by Regions (2015-2020)
Table 99. North America Drugs for Pain Management Revenue by Countries (2015-2020)
Table 100. North America Drugs for Pain Management Revenue Market Share by Countries (2015-2020)
Table 101. Europe Drugs for Pain Management Revenue (Million USD) by Countries (2015-2020)
Table 102. Asia-Pacific Drugs for Pain Management Revenue (Million USD) by Countries (2015-2020)
Table 103. South America Drugs for Pain Management Revenue by Countries (2015-2020)
Table 104. South America Drugs for Pain Management Revenue Market Share by Countries (2015-2020)
Table 105. Middle East and Africa Drugs for Pain Management Revenue (Million USD) by Countries (2015-2020)
Table 106. Middle East and Africa Drugs for Pain Management Revenue Market Share by Countries (2015-2020)
Table 107. Global Drugs for Pain Management Revenue (Million USD) by Type (2015-2020)
Table 108. Global Drugs for Pain Management Revenue Share by Type (2015-2020)
Table 109. Global Drugs for Pain Management Revenue Forecast by Type (2021-2025)
Table 110. Global Drugs for Pain Management Revenue by Application (2015-2020)
Table 111. Global Drugs for Pain Management Revenue Share by Application (2015-2020)
Table 112. Global Drugs for Pain Management Revenue Forecast by Application (2021-2025)
Table 113. Global Drugs for Pain Management Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Drugs for Pain Management Picture
Figure 2. Global Drugs for Pain Management Revenue Market Share by Type in 2019
Figure 3. Generic Opioid Picture
Figure 4. Branded Opioids Picture
Figure 5. NSAIDs Picture
Figure 6. Others Picture
Figure 7. Drugs for Pain Management Revenue Market Share by Application in 2019
Figure 8. Hospitals Picture
Figure 9. Drugstores Picture
Figure 10. Others Picture
Figure 11. Global Drugs for Pain Management Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America Drugs for Pain Management Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe Drugs for Pain Management Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific Drugs for Pain Management Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America Drugs for Pain Management Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa Drugs for Pain Management Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Drugs for Pain Management Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Drugs for Pain Management Revenue Share by Players in 2019
Figure 19. Global Top 5 Players Drugs for Pain Management Revenue Market Share in 2019
Figure 20. Global Top 10 Players Drugs for Pain Management Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global Drugs for Pain Management Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global Drugs for Pain Management Revenue Market Share by Regions (2015-2020)
Figure 24. Global Drugs for Pain Management Revenue Market Share by Regions in 2018
Figure 25. North America Drugs for Pain Management Revenue and Growth Rate (2015-2020)
Figure 26. Europe Drugs for Pain Management Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific Drugs for Pain Management Revenue and Growth Rate (2015-2020)
Figure 28. South America Drugs for Pain Management Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa Drugs for Pain Management Revenue and Growth Rate (2015-2020)
Figure 30. North America Drugs for Pain Management Revenue Market Share by Countries (2015-2020)
Figure 31. North America Drugs for Pain Management Revenue Market Share by Countries in 2019
Figure 32. USA Drugs for Pain Management Revenue and Growth Rate (2015-2020)
Figure 33. Canada Drugs for Pain Management Revenue and Growth Rate (2015-2020)
Figure 34. Mexico Drugs for Pain Management Revenue and Growth Rate (2015-2020)
Figure 35. Europe Drugs for Pain Management Revenue Market Share by Countries (2015-2020)
Figure 36. Europe Drugs for Pain Management Revenue Market Share by Countries in 2019
Figure 37. Germany Drugs for Pain Management Revenue and Growth Rate (2015-2020)
Figure 38. UK Drugs for Pain Management Revenue and Growth Rate (2015-2020)
Figure 39. France Drugs for Pain Management Revenue and Growth Rate (2015-2020)
Figure 40. Russia Drugs for Pain Management Revenue and Growth Rate (2015-2020)
Figure 41. Italy Drugs for Pain Management Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Drugs for Pain Management Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific Drugs for Pain Management Revenue Market Share by Countries in 2019
Figure 44. China Drugs for Pain Management Revenue and Growth Rate (2015-2020)
Figure 45. Japan Drugs for Pain Management Revenue and Growth Rate (2015-2020)
Figure 46. Korea Drugs for Pain Management Revenue and Growth Rate (2015-2020)
Figure 47. India Drugs for Pain Management Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia Drugs for Pain Management Revenue and Growth Rate (2015-2020)
Figure 49. South America Drugs for Pain Management Revenue Market Share by Countries (2015-2020)
Figure 50. South America Drugs for Pain Management Revenue Market Share by Countries in 2019
Figure 51. Brazil Drugs for Pain Management Revenue and Growth Rate (2015-2020)
Figure 52. Argentina Drugs for Pain Management Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa Drugs for Pain Management Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa Drugs for Pain Management Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia Drugs for Pain Management Revenue and Growth Rate (2015-2020)
Figure 56. UAE Drugs for Pain Management Revenue and Growth Rate (2015-2020)
Figure 57. Egypt Drugs for Pain Management Revenue and Growth Rate (2015-2020)
Figure 58. South Africa Drugs for Pain Management Revenue and Growth Rate (2015-2020)
Figure 59. Global Drugs for Pain Management Revenue Share by Type (2015-2020)
Figure 60. Global Drugs for Pain Management Revenue Share by Type in 2019
Figure 61. Global Drugs for Pain Management Market Share Forecast by Type (2021-2025)
Figure 62. Global Generic Opioid Revenue Growth Rate (2015-2020)
Figure 63. Global Branded Opioids Revenue Growth Rate (2015-2020)
Figure 64. Global NSAIDs Revenue Growth Rate (2015-2020)
Figure 65. Global Others Revenue Growth Rate (2015-2020)
Figure 66. Global Drugs for Pain Management Revenue Share by Application (2015-2020)
Figure 67. Global Drugs for Pain Management Revenue Share by Application in 2019
Figure 68. Global Drugs for Pain Management Market Share Forecast by Application (2021-2025)
Figure 69. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 70. Global Drugstores Revenue Growth Rate (2015-2020)
Figure 71. Global Others Revenue Growth Rate (2015-2020)
Figure 72. Global Drugs for Pain Management Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global Drugs for Pain Management Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global Drugs for Pain Management Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America Drugs for Pain Management Revenue Market Forecast (2021-2025)
Figure 76. Europe Drugs for Pain Management Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific Drugs for Pain Management Revenue Market Forecast (2021-2025)
Figure 78. South America Drugs for Pain Management Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa Drugs for Pain Management Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel

---